Candidemia in liver transplant recipients: a ten-year retrospective study - 19/11/26
, Ferhat Özer a
, Yaşar Bayındır b
, Elif Seren Tanrıverdi c
, Ertuğrul Karabulut d
, Sibel Altunışık Toplu a
, Zeynep Burçin Yılmaz a
, Funda Memişoğlu a
, Cemil Çolak e 
Highlights |
• | The 10-year cumulative incidence of candidemia after liver transplantation was 4.25%. |
• | Non-albicans Candida species accounted for 62.5% of candidemia episodes. |
• | Candida glabrata and Candida parapsilosis were the leading non-albicans species. |
• | Anidulafungin was the most frequently prescribed pathogen-directed antifungal agent. |
• | Mortality during active candidemia was 31.3% in liver transplant recipients. |
Abstract |
Background |
Candidemia remains a major invasive fungal infection after liver transplantation (LT), with substantial morbidity and mortality. This study evaluated its cumulative incidence, microbiological characteristics, clinical features, antifungal treatment, and outcomes in a high-volume LT center.
Methods |
We retrospectively reviewed 1,880 adult LT recipients who underwent transplantation and were regularly followed at our institution between January 2015 and January 2025. Eighty patients with candidemia were identified. Demographic and clinical characteristics, Candida species distribution, antifungal treatment, and outcomes were analyzed; available antifungal susceptibility data were evaluated descriptively.
Results |
The 10-year cumulative incidence of candidemia was 4.25% (80/1,880). Most patients (91.3%) had undergone living-donor LT, and 62.5% were in the intensive care unit at candidemia onset. Central venous catheters were present in 75.0%, and renal replacement therapy was required in 46.3%. Non-albicans Candida species accounted for 62.5% of episodes. Candida glabrata (22.5%) and Candida parapsilosis (21.3%) were the most frequent. Blood culture clearance was documented in 81.3% of patients. Anidulafungin was the most frequently prescribed pathogen-directed antifungal agent (61.3%). Twenty-five patients (31.3%) died during active candidemia.
Conclusions |
Candidemia remains a clinically important complication after LT and is associated with substantial mortality. Non-albicans Candida species predominated in this predominantly living-donor LT cohort. These findings highlight the importance of local epidemiological surveillance and prompt, appropriate antifungal management in LT recipients.
Le texte complet de cet article est disponible en PDF.Keywords : Candidemia, Liver transplantation, Living-donor liver transplantation, Non-albicans Candida , Treatment outcomes
Plan
Vol 36 - N° 4
Article 101663- décembre 2026 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
